Loading organizations...
§ Private Profile · Cleveland, OH, USA
DBS neuromodulation and rehabilitation therapy for stroke patients to restore arm motor function. Clinical-stage medical device.
Based in Cleveland, Ohio, Enspire DBS Therapy is a clinical-stage medical device company developing an implantable neuromodulation system that combines deep brain stimulation with physical therapy to restore arm motor function in stroke patients. Founded in 2010 by CEO Scott Kokones, the enterprise operates with fewer than 25 employees and generates under $5 million in annual revenue. The Cleveland Clinic portfolio company has raised at least $27.9 million in total venture capital funding, including backing from institutional investors like JobsOhio Ventures. In January 2026, Enspire announced a $10.3 million Series B1 financing round led by Genesys Capital's Jamie Stiff to support continued patient enrollment in its RESTORE pivotal clinical trial. This recent capital injection follows an August 2023 publication in Nature Medicine detailing the company's EDEN trial results, which demonstrated meaningful improvements in motor impairment for study participants.
Enspire DBS Therapy has raised $10.3M across 1 funding round.
Enspire DBS Therapy has raised $10.3M in total across 1 funding round.
Enspire DBS Therapy has raised $10.3M across 1 funding round. Most recently, it raised $10.3M Series B in January 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 13, 2026 | $10.3M Series B | Jamie Stiff | Cleveland Clinic, Jobsohio Ventures | Announced |
Enspire DBS Therapy has raised $10.3M in total across 1 funding round.
Enspire DBS Therapy's investors include Jamie Stiff, Cleveland Clinic, JobsOhio Ventures.